The Sentinel

THE OFFICIAL BLOG OF THE SOCIETY FOR IMMUNOTHERAPY OF CANCER (SITC).

On Tap at SITC 2017 - Nov. 8, 2017

The Society for Immunotherapy of Cancer (SITC) is pleased to welcome our delegates to the 32nd Annual Meeting & Pre-Conference Programs! We are thankful for the throngs of member leaders and faculty who dedicated so many hours to ensure the SITC Annual Meeting continues being the premier destination for research in the field of cancer immunotherapy.

On Tap Today


Wednesday kicks off the week's proceedings with the first day of Pre-Conference Programs. Once attendees complete registration to pick up badges and materials, they'll be joining the following sessions:

Immuno-Oncology Biomarkers: Today’s Imperatives for Tomorrow’s Needs

8 a.m. - 12:30 p.m. / Cherry Blossom Ballroom

The SITC Industry Committee has developed a Biomarkers Fair to allow companies and interested academic investigators to present their latest technology. This forum will provide the opportunity for presentation of multiple biomarker development efforts by all sectors and stimulate interactions between biomarker diagnostic innovators with each other and with end-users.


This program on Biomarkers is organized in collaboration with the SITC Industry Committee. The following individuals are recognized for their leadership in developing this session:
  • Adrian Bot, MD, PhD –  Kite Pharma, Inc.
  • Alessandra Cesano, MD, PhD –  Nanostring, Inc.
  • Daniel S. Chen, MD, PhD –  Genentech
  • David Kaufman, MD, PhD –  Merck Research Laboratories
  • Salil Patel, PhD –  Bristol-Myers Squibb
Click here to view the program schedule

2nd World Immunotherapy Council Young Investigator Symposium

1 - 7 p.m. / Cherry Blossom Ballroom


The Society for Immunotherapy of Cancer and the World Immunotherapy Council are dedicated to advancing cancer immunotherapy and, likewise, the future leaders of the field. This program will provide the opportunity for young scientists and future leaders from throughout the world to interact, fulfilling the World Immunotherapy Council’s mission to facilitate rapid development and global dissemination of cancer immunotherapies through scientific exchange.

This program is organized in collaboration with the World Immunotherapy Council. The following individuals are recognized for their leadership in developing this program:
  • Tanja D. De Gruijl, PhD – VU University Medical Center
  • Brad Nelson, PhD – BC Cancer Agency, Deeley Research Centre
  • Graham P. Pawelec, PhD – University of Tuebingen
Click here to view the program schedule

The Checkpoints this Saturday


The legendary CheckPoints concert will once again rock delegates' socks off beginning 8:30 p.m. Saturday in the Maryland Ballroom. Have you cleared your schedule? Come dance the night away with luminaries in the field as they play some of your favorite hits.


No comments:

Post a Comment